American Oriental Bioengineering, Inc.
AOBI · OTC
12/31/2012 | 12/31/2011 | 12/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Revenue | $145,100 | $212,690 | $305,944 | $296,151 |
| % Growth | -31.8% | -30.5% | 3.3% | – |
| Cost of Goods Sold | $100,742 | $112,940 | $148,187 | $129,368 |
| Gross Profit | $44,358 | $99,751 | $157,758 | $166,783 |
| % Margin | 30.6% | 46.9% | 51.6% | 56.3% |
| R&D Expenses | $6,246 | $12,658 | $15,365 | $7,922 |
| G&A Expenses | $49,726 | $51,352 | $66,440 | $62,165 |
| SG&A Expenses | $78,751 | $66,263 | $105,361 | $94,062 |
| Sales & Mktg Exp. | $29,025 | $14,911 | $38,921 | $31,897 |
| Other Operating Expenses | $14,334 | $23,120 | $6,662 | $6,039 |
| Operating Expenses | $130,689 | $142,867 | $127,388 | $108,023 |
| Operating Income | -$54,972 | -$3,545 | $30,370 | $58,760 |
| % Margin | -37.9% | -1.7% | 9.9% | 19.8% |
| Other Income/Exp. Net | -$2,529 | -$64,311 | -$6,975 | -$4,241 |
| Pre-Tax Income | -$57,501 | -$67,856 | $23,394 | $54,519 |
| Tax Expense | $2,224 | $635 | $9,335 | $13,217 |
| Net Income | -$59,713 | -$68,491 | $14,087 | $41,421 |
| % Margin | -41.2% | -32.2% | 4.6% | 14% |
| EPS | -781.24 | -901.8 | 190.38 | 1,112.22 |
| % Growth | 13.4% | -573.7% | -82.9% | – |
| EPS Diluted | -781.24 | -901.8 | 185.37 | 1,062.12 |
| Weighted Avg Shares Out | 76 | 75 | 75 | 74 |
| Weighted Avg Shares Out Dil | 76 | 75 | 76 | 89 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $5,835 | $6,610 | $5,900 | $5,746 |
| Depreciation & Amortization | $12,029 | $12,470 | $12,705 | $12,439 |
| EBITDA | -$39,637 | -$48,777 | $41,999 | $72,705 |
| % Margin | -27.3% | -22.9% | 13.7% | 24.5% |